327 related articles for article (PubMed ID: 6594194)
1. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
3. Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis.
Qi DY; Perkins SL; Kling SJ; Russell RG
J Cell Biochem; 1999 Mar; 72(3):387-95. PubMed ID: 10022520
[TBL] [Abstract][Full Text] [Related]
4. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
Gniadecki R
Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1,25(OH)2D3 on normal human CFU-GM: target cells of the agent in the suppression of colony formation and induction of macrophage colonies.
Takahashi T; Suzuki A; Ichiba S; Okuno Y; Sugiyama H; Imura H; Nakamura K; Iho S; Hoshino T
Int J Hematol; 1991 Feb; 54(1):57-63. PubMed ID: 1954352
[TBL] [Abstract][Full Text] [Related]
6. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
7. Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts.
Lee YY; Kim ES; Seol JG; Kim BK; Binderup L; Elstner E; Park DJ; Koeffler HP
Leukemia; 1996 Nov; 10(11):1751-7. PubMed ID: 8892678
[TBL] [Abstract][Full Text] [Related]
8. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 and the regulation of the differentiation and function of macrophages and granulocytes.
Shezen E; Goldman R
Int J Cell Cloning; 1985 Mar; 3(2):65-80. PubMed ID: 3839007
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 induces normal mononuclear blood cells to differentiate in the direction of monocyte-macrophages.
Choudhuri U; Adams JA; Byrom N; McCarthy DM; Barrett J
Haematologia (Budap); 1990; 23(1):9-19. PubMed ID: 2397925
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures.
Dorshkind K; Reichel H; Norman AW
Exp Hematol; 1989 Jun; 17(5):436-42. PubMed ID: 2785458
[TBL] [Abstract][Full Text] [Related]
12. Effect of 1,25-dihydroxyvitamin D3 and 13-cis-retinoic acid on in vitro hematopoiesis in the myelodysplastic syndromes.
Nagler A; Rikilis I; Tatarsky I; Fabian I
J Lab Clin Med; 1987 Aug; 110(2):237-44. PubMed ID: 3474327
[TBL] [Abstract][Full Text] [Related]
13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]].
Irino S; Taoka T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981
[TBL] [Abstract][Full Text] [Related]
15. The effect of vitamin D3 metabolites on normal and leukemic bone marrow cells in vitro.
McCarthy D; Hibbin J; San Miguel JF; Freake H; Rodrigues B; Andrews C; Pinching A; Catovsky D; Goldman JM
Int J Cell Cloning; 1984 Jul; 2(4):227-42. PubMed ID: 6086776
[TBL] [Abstract][Full Text] [Related]
16. Myeloid progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail to respond to 1,25(OH)2D3.
Nagler A; Merchav S; Fabian I; Tatarsky I; Weisman Y; Hochberg Z
Br J Haematol; 1987 Nov; 67(3):267-71. PubMed ID: 2825755
[TBL] [Abstract][Full Text] [Related]
17. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemias.
Blazsek I; Farabos C; Quittet P; Labat ML; Bringuier AF; Triana BK; Machover D; Reynes M; Misset JL
Cancer Detect Prev; 1996; 20(1):31-42. PubMed ID: 8907201
[TBL] [Abstract][Full Text] [Related]
19. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
[TBL] [Abstract][Full Text] [Related]
20. 1 alpha, 25-Dihydroxyvitamin D3 augments clonal growth of macrophages from rat bone marrow progenitor cells and modulates their function.
Shezen E; Goldman R
Int J Cell Cloning; 1986 Mar; 4(2):115-25. PubMed ID: 3754272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
